AgeX Therapeutics, Inc. (AGE)の価格はいくらですか

AgeX Therapeutics, Inc. (AGE)の価格は$11.10です

AgeX Therapeutics, Inc. (AGE)の時価総額は何ですか

AgeX Therapeutics, Inc. (AGE)の時価総額は$27.76Mです

AgeX Therapeutics, Inc.（AGE）の株価履歴

AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-related metabolic disorders, including adult-onset Type II diabetes and obesity. AGEX-VASC1: A cell-based approach aimed at re-establishing vital vascular support in aged ischemic tissues, which could be relevant for conditions such as peripheral vascular disease and ischemic heart disease. Beyond cell therapies, AgeX is also exploring other modalities: Its primary drug candidate in the discovery phase is AGEX-iTR1547, a drug formulation focused on achieving scarless wound repair. For induced tissue regeneration, its leading biologic candidate is AGEX-iTR1550, which leverages gene delivery technology. Furthermore, AgeX maintains a research collaboration with the University of California at Irvine, jointly working to develop cellular therapies for various neurological disorders. Founded in 2017, AgeX Therapeutics, Inc. maintains its headquarters in Alameda, California.

年	パフォーマンス
2024	11.81%
2023	-35.11%
2022	-9.37%
2021	-62.79%
2020	13.31%
2019	-58.69%
2018	0.00%

年

パフォーマンス

2024

11.81%

2023

-35.11%

2022

-9.37%

2021

-62.79%

2020

13.31%

2019

-58.69%

2018

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$552.07	39.99%	US
Moderna, Inc. MRNA.US	$168.77	527.63%	US
Argenx SE ARGX.US	$1.03K	56.22%	NL
CSL Limited CSL.AX	$121.86	-14.20%	AU
Lonza Group AG LONN.SW	$753.28	5.84%	CH

企業

株価

変化率 1年%

国